Lung Flashcards

1
Q

lining epithelium of lung structures

A

upto lobular bronchiole: pseudo stratified ciliated columnar epithelium
terminal and respiratory bronchiole: low columnar or cuboidal with cilia
rest of the part: simple squamous cell epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

histological classification of lung cancer broadly

A
**Epithelial tumors:**
--adenocarcinoma
--squamous cell carcinoma
--adeno squamous carcinoma
--neuro endocrine tumors
--large cell
--sarcomatoid
Mesenchymal tumors
Lymphohistiocytic tumors
Tumors of ectopic origin
Metastatic tumors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Classification of adenocarcinoma

A
lepidic
acinar
papillary
micro papillary
solid
colloidal
fetal adenocarcinoma
enteric
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

squamous cell carcinoma classification

A

keratinizing
non keratinizing
basaloid
SCC in situ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

types of sarcomatoid carcinoma in lung

A
pleomorphic carcinoma
spindle cell carcinoma
giant cell carcinoma
carcinosarcoma
pulmonary blastoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

types of mesenchymal tumors

A
pulmonary hamartoma
chondroma
pecomatous tumors
synovial sarcoma
pulmonary artery intimal sarcoma
pulmonary myxoid sarcoma
myoepithelial tumor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Lymph node zone of lung: N2

A
1=low cervical, supraclavicular
2=upper paratracheal
3=pre vascular, retro tracheal
4=lower paratracheal
5=sub aortic
6=para aortic
7= sub carinal
8=para esophageal
9= pulmonary ligament
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Lymph node zone of lung N1

A
10=hilar nodes
11=inter lobar 
12=lobar
13=segmental
14=sub segmental
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Endocrine PNS of lung cancer

A
SIADH
cushing syndrome
carcinoid syndrome
hypercalcemia
hypercalcitonemia
hyperthyroidism
hypoglycemia
gynecomastia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Neurologic PNS

A
Encephalopathy
sub acute cerebellar degeneration
progressive multifocal leukoencephalopathy
peripheral neuropathy
autonomic neuropathy
Lambert Eaton syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

SIADH diagnostic Criteria

A

serum osmolarity: < 275 mosm/kg
urine osmolarity >100 mosm/kg
clinical euvolemia
urine Na> 30 mmol/L with normal dietary salt and water
absence of adrenal, thyroid, pituitary or renal insuff
no recent use of diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Chemotherapy causing SIADH

A
cisplatin
cyclophosphamide
ifosfamide
vincristine
vinorelbine
vinblastine
MTX
imatinib
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pancoast tumor

A

it is the tumor that arises from apex of lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pancoasts syndrome

A

this is characterized by the pain in the shoulder or inner aspect of arm along the ulnar nerve distribution due to the involvement of lower part of brachial plexus. (C8, T1, T2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Horners syndrome

A

it is a combination of S/S caused by disruption of cervical sympathetic nerve pathway as it passes through T1 root and characterized by ptosis, miosis, enopthalmus, ipsilateral anhydrosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Maker IHC for adenocarcinoma

A

TTF 1 +ve
Napsin a +ve
Ck 7+ve
Ck 20-ve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Sq cell carcinoma IHC

A

TTF1 -ve
p40 +ve
p63 +ve
ck 5/6 +ve

18
Q

Small cell lung cancer IHC

A
NSE > 100 mcg/dl(+ve)
CD 56 +ve
chromogranin +ve
synoptophysin +ve
ki 67 (50-100%)
19
Q

Mesothelioma IHC

A

To confirm: WT1, calretinin, D2-40
To exclude: CEA, TTF1, Claudin-4
BAP-1 IHC specific marker to distinguish mesothelioma from reactive mesothelial proliferation

20
Q

Dose limitation for lung

A

mean <20 gy

combined volume of both normal lung v20<35%

21
Q

Heart dose limitation

A

V40<80%
v60 <30%
mean <35 gy

22
Q

Prognostic factors of lung cancer

A

patient age, sex, weight loss and performance stats
staging
tumor histology:sqcc better prognosis
LDH, Albumin, Hb

23
Q

five year survival of NSCLC

A

stage I: 68-92%
Stage II: 53-60%
stage III: 13-36%
stage IV: 0-10%

24
Q

Nodal disease estimation:
EBUS: Stations
EUS : stations

A

Ebus: 2r/l, 4R/L, 7, 10 R/L
EUS: 5,7,8,9
TTNA(anterior mediastinotomy): 5,6

25
method of pathological mediastinal lymph node evaluation
``` mediastinoscopy mediastinotomy EBUS EUS CT guided biopsy ```
26
Stage IV a , C/L lung nodule: how to treat
treat as two primary lung tumors if both curable
27
Follow up protocol: Stage I and II
H&P , contrast CT chest+-contrast 6 monthly 3 yrs | than H&P and low dose ct scan contrast annually
28
follow up for stage I-II(if rx with RT) | stage III IV (definitive intent treatment)
``` H&P, contrast CT +- 3-6 monthly 3 yr than H&P , chest CT +-contrast 6 monthly 2 yr than LDCT annually smoking cessation pet/CT & brain MRI cancer survivor ship ```
29
Lung cancer prognostic factor
Female sex Ps Wt loss Staging ( rakib sir favrt question)
30
lung lymph node station: N1
10: hilar 11: interlobal 12: lobar 13. segmental 14. subsegmental
31
lung lymph node station: N2
supraclavicular zone: 1. low cervical, supraclavicular superior mediastinal: 2R,L: upper paratracheal 3a: prevascular 3p: Retrotracheal 4R: lower paratracheal 4L: lower paratracheal left 5: Sub aortic 6: para aortic 7. Sub carinal 8. paraesophageal 9. pulmonary ligament
32
Squamous cell carcinoma lung : curative dose
Curative: 55gy in 20 fractions 2.75 gy in 4 weeks 64-66 gy in 32-33 daily fractions given in a six and a half weeks
33
Nsclc sbrt dose
60 gy in 8 fractions on a alternate days 60 gy in 5 fractions weekly ( nazir sir)
34
Curative small cell lung dose
40 gy in 15 fractions 2.67 gy bid 6 hours gap in 3 weeks 45 gy in 15 fraction 1.5 gy BID 6 hours apart over 3 weeks (nazir mollah favorite)
35
PCI dose in ca lung
25 gy in 10 daily fractions of 2.5 gy given in 2 weeks
36
PCI used in
Small cell lung carcinoma Leukemia
37
Difference between pleural effusion due to carcinoma or infective cause
The characteristics of pleural fluid can help differentiate between malignant and infective causes. In general, malignant pleural effusions tend to have higher protein and lactate dehydrogenase (LDH) levels than non-malignant effusions 2. Additionally, malignant effusions are more likely to be exudative, meaning that they contain high levels of cells and other substances 2. In contrast, transudative effusions are more commonly associated with non-malignant causes such as heart failure or liver disease 2
38
Complication of RT in lung
COMPLICATIONS … **Acute** esophagitis, dermatitis, cough, fatigue. … **Subacute/late** radiation pneumonitis, pulmonary fibrosis, esophageal stricture or perforation, pericarditis, coronary artery disease, brachial plexopathy, rib fracture. 2nd malignancy
39
How smoking cause lung cancer
Cigarette smoking is by far the leading cause of lung cancer, accounting for approximately 80% to 90% of cases. Combustion of tobacco produces multiple known carcinogens, with the most important including polycyclic aromatic hydrocarbons, tobac- co-specific nitrosamines, and nitrates
40
Sensitivity and specificity of CT scan and PET CT for identifying lung lesion
**CT scan** Sensitivity: 55% Specificity: 81% **PET CT** Sensitivity 80% Specificity 88%
41
Common paraneoplastic syndrome of lung
Hypercalcemia SIADH Cushing syndrome Lambert eaton myasthenic syndrome Paraneoplastic encephalitits Unexplained hematologic abnormalities Hypercoagulability with venous thromboembolic disease Hypertrophic pulmonary osteoarthropathy Dermatomyositis and polymyositis